Counterfactual Reasoning in Observational Studies

Negar HassanpourAAAI 2019 · OpenReview

Abstract

To identify the appropriate action to take, an intelligent agent must infer the causal effects of every possible action choice. A prominent example is precision medicine that attempts to identify which medical procedure will benefit each individual patient the most. This requires answering counterfactual questions such as: "Would this patient have lived longer, had she received an alternative treatment?". In my PhD, I attempt to explore ways to address the challenges associated with causal effect estimation; with a focus on devising methods that enhance performance according to the individual-based measures (as opposed to population-based measures).

Introduction

In clinical practice, a fundamental question often arises: "If a different treatment had been administered, would the patient's outcome have improved?" This inquiry lies at the heart of counterfactual reasoning. While Randomized Controlled Trials (RCTs) provide the most reliable answers, they are frequently impractical due to ethical constraints, high costs, or time requirements. Consequently, researchers must rely on observational data—real-world clinical records—to derive causal insights. This paper outlines a research framework for leveraging machine learning to estimate individual treatment effects (ITE) from such data.

The Challenge of Causal Inference

The primary obstacle in this field is the Fundamental Problem of Causal Inference: for any individual, we only observe the outcome of the treatment they actually received. The "counterfactual" outcome—what would have happened under an alternative treatment—remains unobserved.

Observed outcomes (solid) vs. counterfactual outcomes (faded) for medication (t=0) and surgery (t=1).

Standard machine learning models are often ill-equipped for this task due to sample selection bias. In observational settings, treatment assignment is rarely random; for instance, healthier patients might be more likely to receive surgery, while frailer patients receive medication. These factors, known as confounders, influence both the treatment choice and the outcome, leading to biased estimates if not properly addressed. The goal is to move from population-level averages to personalized, individual-based measures of treatment efficacy.

Proposed Methodology

The research roadmap is structured around five key research questions (RQs) designed to overcome the limitations of observational data:

  1. Synthetic Data Generation: To validate models where ground truth counterfactuals are missing, the author proposes algorithms to create realistic synthetic datasets with known outcomes.
  2. Balanced Representation Learning: This involves learning a data representation ($\Phi$) that minimizes the distributional differences between treatment groups, effectively simulating a randomized trial by "blurring" features that drive selection bias.
  3. Generative Modeling: Utilizing Variational Auto-Encoders (VAEs) and Generative Adversarial Networks (GANs) to "imagine" and fill in missing counterfactual outcomes.
  4. Handling Censored Data: Developing survival analysis methods to utilize "time-to-event" data where outcomes are only partially known (e.g., a patient leaves a study before an event occurs).
  5. Multi-Treatment Regression: Extending models beyond binary choices to handle multiple treatment categories, drug combinations, or continuous dosages.

Research Roadmap and Progress

This work, presented at the AAAI-19 Doctoral Consortium, follows a structured timeline for addressing these challenges. Early progress on RQ1 and RQ2 has already been established in previous publications, focusing on evaluation methodologies and shared representation spaces.

Timeline of research milestones and publication targets for the proposed research questions.

The research utilizes the Precision in Estimation of Heterogeneous Effect (PEHE) as a core metric, measuring the accuracy of estimated differences between potential outcomes at the individual level.

Conclusion and Future Directions

While significant strides have been made, challenges remain, particularly regarding unobserved confounders—variables that influence treatment but are not recorded in the data. Future work will also focus on the complexity of multi-drug interactions and the continued refinement of validation techniques using synthetic data to better mirror human biological complexity.

Summary updated

Abstract

To identify the appropriate action to take, an intelligent agent must infer the causal effects of every possible action choices. A prominent example is precision medicine that attempts to identify which medical procedure will benefit each individual patient the most. This requires answering counterfactual questions such as: ""Would this patient have lived longer, had she received an alternative treatment?"". In my PhD, I attempt to explore ways to address the challenges associated with causal effect estimation; with a focus on devising methods that enhance performance according to the individual-based measures (as opposed to population-based measures).
BibTeX
@inproceedings{hassanpour2019counterfactual,
  author = {Negar Hassanpour},
  title = {{Counterfactual Reasoning in Observational Studies}},
  booktitle = {AAAI Conference on Artificial Intelligence},
  year = {2019},
  url = {https://openreview.net/forum?id=AvRdyQ8QaD},
}
Figure